Related Experiment Video
Updated: Jun 9, 2026

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
Published on: December 20, 2024
Knowledge among primary care physicians on urticaria treatment: Impact of educational interventions
Jorge Sánchez1, Ana Caraballo1, Jaime Ocampo2
1Group of Clinical and Experimental Allergy (GACE), "Alma Mater de Antioquia" Hospital, University of Antioquia, Medellín, Colombia.
Background:
Primary care physicians (general practitioners, family physicians, emergency physicians, among others) are often the first point of medical contact for patients with urticaria. Appropriate initial management enables early disease control and reduces the overall burden on patients and health care systems.
Objective:
We evaluated changes over time in primary care physicians' (PCPs) knowledge regarding diagnosis and management of urticaria. Additionally, we explored the characterization of access barriers reported by urticaria specialists.
Methods:
We used a multimodal approach to assess changes in knowledge across two periods (2022 and 2025). Three sources of information were analyzed: (1) a knowledge test using a standardized questionnaire, (2) review of medical records from 3 health care centers, and (3) analysis of the Colombian national medical prescription registration system, SISPRO. Diagnostic and treatment domains were evaluated across all information sources.
Results:
We observed that the level of knowledge of guidelines among PCPs has increased in the different clinical domains (diagnosis, therapy). However, more than 50% of PCPs still have gaps in their understanding of the correct management practices. Several barriers were identified among PCPs but also among specialists (allergists, dermatologists), generally related to the administrative process.
Conclusion:
Educational initiatives appear to positively influence PCPs' knowledge and management of urticaria; however, persistent gaps highlight the need for ongoing, targeted educational strategies and system-level improvements to reduce barriers in medical care.
Related Concept Videos
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Hypersensitivities
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Allergic Reactions: Anaphylaxis
Allergic Reactions